abstract |
The present invention relates to a novel compound which inhibits Lp-PLA 2 activity, a process for its preparation, a composition containing the same, and a use of Lp-PLA 2 in the treatment of diseases associated with the activity of Lp-PLA 2 such as atherosclerosis, . |